DE69633862D1 - Mit granulozytischen ehrlichia infizierten zellinien, impstoffe, nachweis und methoden - Google Patents

Mit granulozytischen ehrlichia infizierten zellinien, impstoffe, nachweis und methoden

Info

Publication number
DE69633862D1
DE69633862D1 DE69633862T DE69633862T DE69633862D1 DE 69633862 D1 DE69633862 D1 DE 69633862D1 DE 69633862 T DE69633862 T DE 69633862T DE 69633862 T DE69633862 T DE 69633862T DE 69633862 D1 DE69633862 D1 DE 69633862D1
Authority
DE
Germany
Prior art keywords
cell line
granulocytic ehrlichia
methods
vaccines
granulocytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69633862T
Other languages
English (en)
Other versions
DE69633862T2 (de
Inventor
T Coughlin
Cindy Gingrich-Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agenus Inc
Original Assignee
Antigenics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/470,358 external-priority patent/US6284238B1/en
Application filed by Antigenics LLC filed Critical Antigenics LLC
Publication of DE69633862D1 publication Critical patent/DE69633862D1/de
Application granted granted Critical
Publication of DE69633862T2 publication Critical patent/DE69633862T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69633862T 1995-06-06 1996-06-06 Mit granulozytischen ehrlichia infizierten zelllnien, impfstoffe, nachweis und methoden Expired - Fee Related DE69633862T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US470358 1995-06-06
US08/470,358 US6284238B1 (en) 1995-06-06 1995-06-06 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US08/613,415 US5976860A (en) 1995-06-06 1996-03-11 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US613415 1996-03-11
PCT/US1996/010117 WO1996039484A1 (en) 1995-06-06 1996-06-06 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods

Publications (2)

Publication Number Publication Date
DE69633862D1 true DE69633862D1 (de) 2004-12-23
DE69633862T2 DE69633862T2 (de) 2005-12-08

Family

ID=27043058

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633862T Expired - Fee Related DE69633862T2 (de) 1995-06-06 1996-06-06 Mit granulozytischen ehrlichia infizierten zelllnien, impfstoffe, nachweis und methoden

Country Status (8)

Country Link
US (1) US5976860A (de)
EP (1) EP0832185B1 (de)
AT (1) ATE282690T1 (de)
AU (1) AU712541B2 (de)
CA (1) CA2223950A1 (de)
DE (1) DE69633862T2 (de)
ES (1) ES2233970T3 (de)
WO (1) WO1996039484A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231869B1 (en) 1997-03-21 2001-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6403093B1 (en) * 1997-03-21 2002-06-11 Mayo Foundation For Medical Education And Research Methods to detect granulocytic ehrlichiosis
US6207169B1 (en) 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6277381B1 (en) * 1997-03-21 2001-08-21 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6673356B1 (en) 1997-03-21 2004-01-06 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
WO1998042743A1 (en) * 1997-03-24 1998-10-01 Merial Canine ehrlichiosis immunogenic and diagnostic compositions and methods
US6306394B1 (en) 1997-04-25 2001-10-23 Aquila Biopharmaceuticals Inc. Nucleic acids, proteins, and methods of use of granulocytic ehrlichia
WO1998049313A2 (en) * 1997-04-25 1998-11-05 Aquila Biopharmaceuticals, Inc. Characterization of granulocytic ehrlichia and methods of use
WO2000006744A1 (en) * 1998-07-28 2000-02-10 Aquila Biopharmaceuticals, Inc. Granulocytic ehrlichia genes and uses thereof
US20030194756A1 (en) * 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
EP1581626A4 (de) * 2002-08-14 2007-01-24 Univ Minnesota Kultivierung von anaplasma
US7507789B2 (en) * 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
US9051557B2 (en) * 2007-09-12 2015-06-09 Intervet International B.V. Method for continuously culturing Ehrlichia canis
AU2008298872A1 (en) * 2007-09-12 2009-03-19 Intervet International B.V. Methods of culturing bacterial species of the Anaplasmataceae family
CA2700476C (en) * 2007-09-21 2017-11-28 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis variable-length pcr target
WO2009039413A2 (en) 2007-09-21 2009-03-26 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis (p120)
US8158370B2 (en) 2007-11-27 2012-04-17 Idexx Laboratories, Inc. Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma
CA3018728A1 (en) 2008-10-08 2010-04-15 Idexx Laboratories, Inc. Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl)
US8257938B2 (en) * 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
US9133525B2 (en) 2012-01-26 2015-09-15 Luc Montagnier Detection of DNA sequences as risk factors for HIV infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4759927A (en) * 1986-12-22 1988-07-26 University Of Maryland Vaccine against Potomac horse fever and method of preparation therefore
US5192679A (en) * 1990-05-03 1993-03-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Growing ehrlichia species in a continuous cell line

Also Published As

Publication number Publication date
US5976860A (en) 1999-11-02
EP0832185A1 (de) 1998-04-01
EP0832185B1 (de) 2004-11-17
AU6331796A (en) 1996-12-24
AU712541B2 (en) 1999-11-11
ATE282690T1 (de) 2004-12-15
ES2233970T3 (es) 2005-06-16
WO1996039484A1 (en) 1996-12-12
DE69633862T2 (de) 2005-12-08
CA2223950A1 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
ATE282690T1 (de) Mit granulozytischen ehrlichia infizierten zellinien, impstoffe, nachweis und methoden
SE0001275L (sv) Öronpropp
DE69111352T2 (de) Verfahren und vorrichtung zur ungefähr vertikal ausgerichteten abwicklung von schläuchen.
DE69101240T2 (de) Isoliersystem und verfahren zur herstellung eines solchen isoliersystems an einer leitung oder an einem container.
AT353723B (de) Verfahren zur verbesserung eines aus muell her- gestellten fasermaterials und anlage zur durch- fuehrung des verfahrens
SE9801287D0 (sv) Incorporation of active substances in carrier matrixes
ATE272409T1 (de) Verfahren zur erzeugung aktiver immunität durch vakzinkonjugate
DE69930166D1 (de) Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen
DE69105626T2 (de) Vorrichtung zum Wickeln und Verpacken von aus Kohlenstoff bestehenden bandförmigen Faserbündeln.
DE69005987T2 (de) Dichtung, Vorrichtung und Verfahren zur ihrer Herstellung.
FI973484A0 (fi) Menetelmä immuunivasteen stimuloimiseksi
DE69105980T2 (de) Einlasskrümmer-brennstoffleitung und verfahren.
ATE291230T1 (de) Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden
CH617306B (de) Verfahren zur herstellung eines effektgarns mit noppenfoermigen verdickungen.
DE69106275D1 (de) Verfahren und Vorrichtung zur Abgrabung des Meeresbodens.
DE69112909D1 (de) Verfahren und Vorrichtung zur Kultivierung von anaeroben Keimen.
DE3850378D1 (de) Vorrichtung zur pneumatischen Kraftstoffeinspritzung.
ATE196811T1 (de) Einrichtung zur abschreckung von tierischen schädlingen mittels ultraschall und verfahren zu deren herstellung
DE68924094T2 (de) Gerät zur Erkennung des Motorbremsens.
DE68905273T2 (de) Vorrichtung zur herstellung von yoghurt.
DE69113508T2 (de) Verfahren und Vorrichtung zur Herstellung von Kernbrennstabbündelabstandshaltern.
DE3875645D1 (de) Verfahren und kontrollgeraet zur verschluesselung einer nachricht gemaess eines algorithmus mit oeffentlichem schluessel.
DK1077999T3 (da) Moraxella catarrhalis-proteiner
DE58908543D1 (de) Verfahren und vorrichtung zur herstellung dünner schichten.
ATE377944T1 (de) Methode für die behandlung einer hepatitisvirusinfektion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee